TOKYO: Takeda Pharmaceutical Co said on Wednesday (Mar 4)Â it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.
The Japanese drug maker is working on a plasma-derived therapy⦠[+1042 chars]Source
